Hereditary Prostate Cancer

Aubrey R. Turner, Jianfeng Xu, William B Isaacs

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter focuses on the hereditary components of prostate cancer. All cancer has a genetic component, yet only a fraction of cancers are hereditary. While hereditary mutations are present in every cell of the body, somatic mutations are present only in cells that arise from a specific somatic cell. Many inherited mutations do not unilaterally cause cancer, but typically increase the risk of developing cancer due to subsequent somatic events. Family studies have utilized the variable balance of genetics and environment to quantify the risk of prostate cancer, thus providing the basis for family history risk assessment. With the role of genetics firmly established by twin studies and the increased risk quantified by family studies, several complex segregation analyses were undertaken to identify the most likely mode of inheritance for prostate cancer genes. Linkage analyses identify and define specific chromosomal regions associated with inheritance of a disease of interest, such as prostate cancer. This involves tracing the inheritance of multiple genetic landmarks (genetic markers) within families to identify landmarks associated with the disease and to measure the extent of this linkage. Advances in molecular biology, laboratory automation, and analytical capabilities have accelerated the search for hereditary prostate cancer genes.

Original languageEnglish (US)
Title of host publicationProstate Cancer: Science and Clinical Practice
PublisherElsevier Ltd.
Pages145-158
Number of pages14
ISBN (Print)9780122869815
DOIs
StatePublished - Jul 2003

Fingerprint

Prostatic Neoplasms
Neoplasm Genes
Genes
Mutation
Neoplasms
Molecular biology
Laboratory Automation
Risk assessment
Twin Studies
Automation
Genetic Markers
Molecular Biology
Familial Prostate cancer
Genetics
Cell Body

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Turner, A. R., Xu, J., & Isaacs, W. B. (2003). Hereditary Prostate Cancer. In Prostate Cancer: Science and Clinical Practice (pp. 145-158). Elsevier Ltd.. https://doi.org/10.1016/B978-012286981-5/50018-5

Hereditary Prostate Cancer. / Turner, Aubrey R.; Xu, Jianfeng; Isaacs, William B.

Prostate Cancer: Science and Clinical Practice. Elsevier Ltd., 2003. p. 145-158.

Research output: Chapter in Book/Report/Conference proceedingChapter

Turner, AR, Xu, J & Isaacs, WB 2003, Hereditary Prostate Cancer. in Prostate Cancer: Science and Clinical Practice. Elsevier Ltd., pp. 145-158. https://doi.org/10.1016/B978-012286981-5/50018-5
Turner AR, Xu J, Isaacs WB. Hereditary Prostate Cancer. In Prostate Cancer: Science and Clinical Practice. Elsevier Ltd. 2003. p. 145-158 https://doi.org/10.1016/B978-012286981-5/50018-5
Turner, Aubrey R. ; Xu, Jianfeng ; Isaacs, William B. / Hereditary Prostate Cancer. Prostate Cancer: Science and Clinical Practice. Elsevier Ltd., 2003. pp. 145-158
@inbook{f428a3452479455fa4031cdc6a3a6a6f,
title = "Hereditary Prostate Cancer",
abstract = "This chapter focuses on the hereditary components of prostate cancer. All cancer has a genetic component, yet only a fraction of cancers are hereditary. While hereditary mutations are present in every cell of the body, somatic mutations are present only in cells that arise from a specific somatic cell. Many inherited mutations do not unilaterally cause cancer, but typically increase the risk of developing cancer due to subsequent somatic events. Family studies have utilized the variable balance of genetics and environment to quantify the risk of prostate cancer, thus providing the basis for family history risk assessment. With the role of genetics firmly established by twin studies and the increased risk quantified by family studies, several complex segregation analyses were undertaken to identify the most likely mode of inheritance for prostate cancer genes. Linkage analyses identify and define specific chromosomal regions associated with inheritance of a disease of interest, such as prostate cancer. This involves tracing the inheritance of multiple genetic landmarks (genetic markers) within families to identify landmarks associated with the disease and to measure the extent of this linkage. Advances in molecular biology, laboratory automation, and analytical capabilities have accelerated the search for hereditary prostate cancer genes.",
author = "Turner, {Aubrey R.} and Jianfeng Xu and Isaacs, {William B}",
year = "2003",
month = "7",
doi = "10.1016/B978-012286981-5/50018-5",
language = "English (US)",
isbn = "9780122869815",
pages = "145--158",
booktitle = "Prostate Cancer: Science and Clinical Practice",
publisher = "Elsevier Ltd.",

}

TY - CHAP

T1 - Hereditary Prostate Cancer

AU - Turner, Aubrey R.

AU - Xu, Jianfeng

AU - Isaacs, William B

PY - 2003/7

Y1 - 2003/7

N2 - This chapter focuses on the hereditary components of prostate cancer. All cancer has a genetic component, yet only a fraction of cancers are hereditary. While hereditary mutations are present in every cell of the body, somatic mutations are present only in cells that arise from a specific somatic cell. Many inherited mutations do not unilaterally cause cancer, but typically increase the risk of developing cancer due to subsequent somatic events. Family studies have utilized the variable balance of genetics and environment to quantify the risk of prostate cancer, thus providing the basis for family history risk assessment. With the role of genetics firmly established by twin studies and the increased risk quantified by family studies, several complex segregation analyses were undertaken to identify the most likely mode of inheritance for prostate cancer genes. Linkage analyses identify and define specific chromosomal regions associated with inheritance of a disease of interest, such as prostate cancer. This involves tracing the inheritance of multiple genetic landmarks (genetic markers) within families to identify landmarks associated with the disease and to measure the extent of this linkage. Advances in molecular biology, laboratory automation, and analytical capabilities have accelerated the search for hereditary prostate cancer genes.

AB - This chapter focuses on the hereditary components of prostate cancer. All cancer has a genetic component, yet only a fraction of cancers are hereditary. While hereditary mutations are present in every cell of the body, somatic mutations are present only in cells that arise from a specific somatic cell. Many inherited mutations do not unilaterally cause cancer, but typically increase the risk of developing cancer due to subsequent somatic events. Family studies have utilized the variable balance of genetics and environment to quantify the risk of prostate cancer, thus providing the basis for family history risk assessment. With the role of genetics firmly established by twin studies and the increased risk quantified by family studies, several complex segregation analyses were undertaken to identify the most likely mode of inheritance for prostate cancer genes. Linkage analyses identify and define specific chromosomal regions associated with inheritance of a disease of interest, such as prostate cancer. This involves tracing the inheritance of multiple genetic landmarks (genetic markers) within families to identify landmarks associated with the disease and to measure the extent of this linkage. Advances in molecular biology, laboratory automation, and analytical capabilities have accelerated the search for hereditary prostate cancer genes.

UR - http://www.scopus.com/inward/record.url?scp=84902219365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902219365&partnerID=8YFLogxK

U2 - 10.1016/B978-012286981-5/50018-5

DO - 10.1016/B978-012286981-5/50018-5

M3 - Chapter

SN - 9780122869815

SP - 145

EP - 158

BT - Prostate Cancer: Science and Clinical Practice

PB - Elsevier Ltd.

ER -